About Us

Annalisa Jenkins, MBBS, FRCP

Chief Executive Officer

Dr. Annalisa Jenkins, MBBS, FRCP is the chief executive officer of Dimension.  A biopharma thought leader with nearly 20 years of industry experience, Dr. Jenkins has built and led teams advancing programs from scientific research through clinical development, regulatory approval and into healthcare systems globally. / Read more +

Sam Wadsworth, PhD

Chief Scientific Officer

Dr. Wadsworth brings extensive drug discovery and development experience in the gene therapy and rare disease area. In his more than 20 years of industry experience at Genzyme and later Sanofi, he oversaw the discovery and translational research on multiple rare disease and gene therapy programs, including Genzyme’s only clinical stage gene therapy program./ Read more +

Mary Thistle

Chief Operating Officer

Ms. Thistle brings extensive experience in the life sciences industry, serving in senior finance, operations, and business development roles. Previously, Ms. Thistle was senior vice president, business development at Cubist Pharmaceuticals. / Read more +

Eric Crombez, MD

Chief Medical Officer

Dr. Crombez brings to Dimension extensive experience and expertise in the development and execution of clinical development programs for rare genetic disorders. / Read more +

K. Reed Clark, PhD

Senior Vice President, Head of Pharmaceutical Development

Reed Clark, Ph.D. is a veteran molecular virologist and gene therapist with extensive experience in preclinical and translational adeno-associated virus (AAV) gene therapy studies. / Read more +

Alex Fotopoulos, MSc, MBA

Senior Vice President, Head of Technical Operations

Mr. Alex Fotopoulos brings to this role over 24 years of experience in global manufacturing and quality operations, biologics facilities and engineering, and clinical and commercial scale CMC operations gained in a range of therapeutic areas. / Read more +

Robert Gaffey

Vice President, Finance

Mr. Gaffey brings nearly 20 years of experience building and managing financial teams in the life-sciences industry. / Read more +

Janet Rae, RAC

Head of Global Regulatory Affairs

Ms. Rae brings over 25 years of regulatory affairs experience in the biopharmaceutical industry, including extensive experience in leading the development of compounds for rare diseases. / Read more +

Khandan Baradaran, PhD

Head of Quality

Khandan Baradaran, Ph.D. is Head of Quality at Dimension Therapeutics. Dr. Baradaran has extensive expertise in the areas of viral safety, gene therapy vector development, vaccine development and assay technologies./ Read more +

Rachel Strauss, MA

Head of Human Resources

Rachel brings broad expertise in human resources, talent management and organizational development within the life sciences industry. Prior to Dimension, Rachel was an accomplished human resources consultant and operated as the human resources leader at several startup biotechnology and medical diagnostics organizations. / Read more +